Jefferies sees private players driving 63% of India’s power capacity additions by FY30. Here are its top power stock picks,…
The Securities and Exchange Board of India (Sebi) has cleared the initial public offerings (IPOs) of city gas distributor Torrent…
Torrent Pharma posted strong Q4 revenue growth led by its India business and rapid gains in the semaglutide market segment.
Sensex, Nifty today, May 14: Sensex jumps nearly 800 points, Nifty closes strong at 23,700; explore top gainers and market…
Over 400 firms, including Cipla, Airtel & Tata Steel, to unveil Q4 results this week. Track key announcements and dividend…
A look at some of the undervalued pharma stocks in India.
Sun Pharma’s mega deal sparks a rally, but Paytm’s RBI shock and Axis Bank’s earnings drag sentiment. Here’s what’s really…
The Indian Pharmaceutical Market (IPM) grew 10.1% year-on-year in March 2026, according to the report. Pricing contributed 5.5% to growth,…
The Indian domestic pharmaceutical market grew to ₹2.46 lakh crore in FY26, fueled by a 13.6% jump in the cardiac…
Monday watchlist, April 05: Track Vedanta, Tata Steel, and top small-caps as technical trends signal possible short-term reversals—review market moves…
This marks a sharp jump from 22 filings in March 2025 and 16 in March 2024, data from the Securities…
Two pharma largecaps—Sun Pharmaceutical Industries Ltd. and Torrent Pharmaceuticals Ltd.—score a perfect 9 on Piotroski, backed by strong financials, growth,…
A sharp sell-off gripped markets as pharma stocks plunged on US tariff fears and rising crude prices dragged key sectors,…
Monday watchlist, March 30: Track Sun Pharma, HDFC Bank and ICICI as market volatility surges; review key stock setups and…
Nomura has a ‘Buy’ rating on Zydus Lifesciences, with the stock at Rs 891 and a target price of Rs…
Ozempic patent expiry has triggered a fresh pharma race in India. Sun Pharma, Cipla, and Dr Reddy’s are among 7…
Jefferies believes NTPC’s earnings growth should remain steady, supported by ongoing capacity additions and consistent operations, which could also help…
Biocon earns USFDA nod for Liraglutide injection, boosting its diabetes drug portfolio. Explore investment opportunities now!